Dawson; Ted M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dawson; Ted M..The latest application filed is for "biomarkers for neurodegenerative disorders".

Company Profile

5.11.17

Dawson; Ted M. - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biomarkers For Neurodegenerative Disorders App 20220291240 - Dawson; Ted M. ; et al.	2022-09-15
Mif Inhibitors And Methods Of Use Thereof App 20220249597 - Dawson; Ted M. ; et al.	2022-08-11
Long-acting Glp-1r Agonist As A Therapy Of Neurological And Neurodegenerative Conditions App 20220111010 - Lee; Seulki ; et al.	2022-04-14
Inhibition Of Rip Kinases For Treating Neurodegenerative Disorders App 20210322427 - LEE; Seulki ; et al.	2021-10-21
Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions Grant 11,123,405 - Lee , et al. September 21, 2	2021-09-21
Mif Inhibitors And Methods Of Use Thereof App 20190224274 - Dawson; Ted M. ; et al.	2019-07-25
THERAPEUTIC USES OF LAG3 THE (alpha)-SYNUCLEIN TRANSMISSION RECEPTOR App 20190194324 - Dawson; Ted M. ; et al.	2019-06-27
Methods Of Preventing Or Treating Parkinson's Disease By The Farnesylation Of Paris App 20190117586 - Shin; Joo-ho ; et al.	2019-04-25
Long-acting Glp-1r Agonist As A Therapy Of Neurological And Neurodegenerative Conditions App 20180369340 - Lee; Seulki ; et al.	2018-12-27
Treatment and prevention of pathological conditions using iduna related techniques and compositions Grant 9,623,039 - Dawson , et al. April 18, 2	2017-04-18
Methods of Making and Using Thioxothiazolidine and Rhodanine Derivatives as HIV-1 and JSP-1 Inhibitors App 20160250194 - Biehl; Edward R. ; et al.	2016-09-01
Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors Grant 9,309,208 - Biehl , et al. April 12, 2	2016-04-12
Transcriptional repression leading to parkinson's disease Grant 9,274,128 - Dawson , et al. March 1, 2	2016-03-01
LRRK-2-Mediated Neuronal Toxicity App 20150018301 - Lee; Byoung Dae ; et al.	2015-01-15
Transcriptional repression leading to Parkinson's disease Grant 8,921,042 - Dawson , et al. December 30, 2	2014-12-30
Transcriptional Repression Leading To Parkinson's Disease App 20140378536 - Dawson; Ted M. ; et al.	2014-12-25
Transcriptional Repression Leading To Parkinson's Disease App 20140045921 - Dawson; Ted M. ; et al.	2014-02-13
Transcriptional repression leading to Parkinson's disease Grant 8,603,994 - Dawson , et al. December 10, 2	2013-12-10
Methods of Making and Using Thioxothiazolidine and Rhodanine Derivatives as HIV-1 and JSP-1 Inhibitors App 20130253021 - Biehl; Edward R. ; et al.	2013-09-26
Transcriptional Repression Leading To Parkinson's Disease App 20120122958 - Dawson; Ted M. ; et al.	2012-05-17
Compounds And Related Methods For Manipulating Parp-1-dependent Cell Death App 20120122765 - Dawson; Ted M. ; et al.	2012-05-17
Treatment And Prevention Of Pathological Conditions Using Iduna Related Techniques And Compositions App 20120121559 - Dawson; Ted M. ; et al.	2012-05-17
Method of using selective parp inhibitors to prevent or treat neurotoxicity Grant 6,358,975 - Eliasson , et al. March 19, 2	2002-03-19
Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors Grant 5,898,029 - Lyons , et al. April 27, 1	1999-04-27
Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity Grant 5,587,384 - Zhang , et al. December 24, 1	1996-12-24

Company Registrations

CAGE Code

46M36

DAWSON, TED M TED M. DAWSON

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.